Grace Therapeutics, Inc. (GRCE) SEC Filings https://www.gracetx.com/investors/sec-filings/annual-reports/rss Grace Therapeutics, Inc. (GRCE) - Annual Reports en-us https://d1io3yog0oux5.cloudfront.net/acastipharma/files/theme/images/Grace_Logo_RGB.png Grace Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[10-K - Annual report [Section 13 and 15(d), not S-K Item 405]]]> https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001140361-25-023259/0001140361-25-023259.pdf Mon, 23 Jun 25 07:44:15 -0400 https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001140361-25-023259/0001140361-25-023259.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0000950170-24-075875/0000950170-24-075875.pdf Fri, 21 Jun 24 07:31:25 -0400 https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0000950170-24-075875/0000950170-24-075875.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0000950170-23-029498/0000950170-23-029498.pdf Fri, 23 Jun 23 07:02:46 -0400 https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0000950170-23-029498/0000950170-23-029498.pdf <![CDATA[10-K/A - Annual report pursuant to Section 13 and 15(d)]]> https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0000950170-22-013526/0000950170-22-013526.pdf Fri, 29 Jul 22 17:28:36 -0400 https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0000950170-22-013526/0000950170-22-013526.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0000950170-22-011842/0000950170-22-011842.pdf Tue, 21 Jun 22 08:09:57 -0400 https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0000950170-22-011842/0000950170-22-011842.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001171843-21-004462/0001171843-21-004462.pdf Tue, 22 Jun 21 07:01:47 -0400 https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001171843-21-004462/0001171843-21-004462.pdf <![CDATA[10-K - Annual report pursuant to Section 13 and 15(d)]]> https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001171843-20-004613/0001171843-20-004613.pdf Mon, 29 Jun 20 16:03:55 -0400 https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001171843-20-004613/0001171843-20-004613.pdf <![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]> https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001171843-19-004174/0001171843-19-004174.pdf Wed, 26 Jun 19 08:13:56 -0400 https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001171843-19-004174/0001171843-19-004174.pdf <![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]> https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001171843-18-004911/0001171843-18-004911.pdf Thu, 03 Jan 19 16:04:10 -0500 https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001171843-18-004911/0001171843-18-004911.pdf <![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]> https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001193125-17-215074/0001193125-17-215074.pdf Thu, 03 Jan 19 16:16:55 -0500 https://www.gracetx.com/investors/sec-filings/all-sec-filings/content/0001193125-17-215074/0001193125-17-215074.pdf